Pulmonary aspergillosis: Recent advances

Seminars in Respiratory and Critical Care Medicine

Volumn 32, Issue 6, 2011, Pages 673-681

  Thompson, George R ^a,b   Patterson, Thomas F ^c,d  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^d SOUTH TEXAS VETERANS HEALTH CARE SYSTEM   (United States)

Author keywords

aspergilloma; Aspergillosis; chronic cavitary aspergillosis

Indexed keywords

AMPHOTERICIN B DEOXYCHOLATE; AMPHOTERICIN B LIPID COMPLEX; ANIDULAFUNGIN; CASPOFUNGIN; CORTICOSTEROID; ITRACONAZOLE; MICAFUNGIN; POSACONAZOLE; TRIAZOLE DERIVATIVE; VORICONAZOLE;

ALLERGIC BRONCHOPULMONARY ASPERGILLOSIS; ARTICLE; ASPERGILLOMA; CHEMOTHERAPY INDUCED EMESIS; CLINICAL FEATURE; COMBINATION CHEMOTHERAPY; DIAGNOSTIC TEST; DIARRHEA; DISEASE PREDISPOSITION; DRUG ERUPTION; EDEMA; GENETIC ANALYSIS; HALLUCINATION; HUMAN; HYPERTRIGLYCERIDEMIA; HYPOKALEMIA; IMMUNE RESPONSE; LOADING DRUG DOSE; LUNG ASPERGILLOSIS; NAUSEA; PATIENT SELECTION; PHOTOPSIA; PRIORITY JOURNAL; PROPHYLAXIS; SIDE EFFECT; UNSPECIFIED SIDE EFFECT; VISUAL IMPAIRMENT;

AMPHOTERICIN B; ANTIFUNGAL AGENTS; ASPERGILLUS; DISEASE SUSCEPTIBILITY; DRUG RESISTANCE, FUNGAL; ECHINOCANDINS; HUMANS; IMMUNOCOMPROMISED HOST; INVASIVE PULMONARY ASPERGILLOSIS; OPPORTUNISTIC INFECTIONS; PULMONARY ASPERGILLOSIS; TRIAZOLES;

EID: 83655193171     PISSN: 10693424     EISSN: 10989048     Source Type: Journal    
DOI: 10.1055/s-0031-1295715     Document Type: Article

References (73)

1. Walsh T J., Anaissie E J., Denning D W. et al, Infectious Diseases Society of America. Treatment of aspergillosis: clinical practice guidelines of the Infectious Diseases Society of America. Clin Infect Dis 2008 46 3 327-360 (Pubitemid 351265310)
2. Patterson T F., Kirkpatrick W R., White M et al. Invasive aspergillosis: disease spectrum, treatment practices, and outcomes. I3 Aspergillus Study Group. Medicine (Baltimore) 2000 79 4 250-260
3. Thompson G R. III, Patterson T F. Pulmonary aspergillosis. Semin Respir Crit Care Med 2008 29 2 103-110 (Pubitemid 351438988)
4. Summerbell R. Ascomycetes: Aspergillus, Fusarium, Sporothrix, Piedraia, and their relatives. In: Howard D H. ed. Pathogenic Fungi in Humans and Animals. 2nd ed. New York Marcel Dekker 2003 237-498
5. Balajee S A., Houbraken J, Verweij P E. et al. Aspergillus species identification in the clinical setting. Stud Mycol 2007 59 39-46 (Pubitemid 351155585)
6. Sutton D A., Fothergill A W., Rinaldi M G. Aspergillus in vitro antifungal susceptibility data: new millennium trends. In: Abstracts of Advances Against Aspergillosis, 911 September, San Francisco, CA, 2004. Abstract 16
7. Balajee S A., Nickle D, Varga J, Marr K A. Molecular studies reveal frequent misidentification of Aspergillus fumigatus by morphotyping. Eukaryot Cell 2006 5 10 1705-1712 (Pubitemid 44622598)
8. Klich M, Pitt J. A Laboratory Guide to Common Aspergillus Species and Their Teleomorphs. North Ryde, New South Wales, Australia Commonwealth Scientific and Industrial Research Organization 1988
9. OGorman C M., Fuller H T., Dyer P S. Discovery of a sexual cycle in the opportunistic fungal pathogen Aspergillus fumigatus. Nature 2009 457 7228 471-474
10. Pitt J I., Samson R A. Nomenclatural considerations in naming species of Aspergillus and its teleomorphs. Stud Mycol 2007 59 67-70 (Pubitemid 351155588)
11. Panackal A A., Li H, Kontoyiannis D P. et al. Geoclimatic influences on invasive aspergillosis after hematopoietic stem cell transplantation. Clin Infect Dis 2010 50 12 1588-1597
12. Portugal R D., Garnica M, Nucci M. Index to predict invasive mold infection in high-risk neutropenic patients based on the area over the neutrophil curve. J Clin Oncol 2009 27 23 3849-3854
13. Patterson J E., Peters J, Calhoon J H. et al. Investigation and control of aspergillosis and other filamentous fungal infections in solid organ transplant recipients. Transpl Infect Dis 2000 2 1 22-28 (Pubitemid 30139961)
14. Singh N, Paterson D L. Aspergillus infections in transplant recipients. Clin Microbiol Rev 2005 18 1 44-69 (Pubitemid 40173979)
15. Paterson D L., Singh N. Invasive aspergillosis in transplant recipients. Medicine (Baltimore) 1999 78 2 123-138 (Pubitemid 29153028)
16. Denning D W. Aspergillosis in nonimmunocompromised critically ill patients. Am J Respir Crit Care Med 2004 170 6 580-581 (Pubitemid 39202196)
17. Lat A, Bhadelia N, Miko B, Furuya E Y., Thompson G R. III. Invasive aspergillosis after pandemic (H1N1) 2009. Emerg Infect Dis 2010 16 6 971-973
18. Meersseman W, Vandecasteele S J., Wilmer A, Verbeken E, Peetermans W E., Van Wijngaerden E. Invasive aspergillosis in critically ill patients without malignancy. Am J Respir Crit Care Med 2004 170 6 621-625 (Pubitemid 39202203)
19. Warris A, Bjørneklett A, Gaustad P. Invasive pulmonary aspergillosis associated with infliximab therapy. N Engl J Med 2001 344 14 1099-1100 (Pubitemid 32267986)
20. Cohen M S., Isturiz R E., Malech H L. et al. Fungal infection in chronic granulomatous disease: the importance of the phagocyte in defense against fungi. Am J Med 1981 71 1 59-66 (Pubitemid 12254714)
21. Gersuk G M., Underhill D M., Zhu L, Marr K A. Dectin-1 and TLRs permit macrophages to distinguish between different Aspergillus fumigatus cellular states. J Immunol 2006 176 6 3717-3724 (Pubitemid 43364018)
22. Hohl T M., Van Epps H L., Rivera A et al. Aspergillus fumigatus triggers inflammatory responses by stage-specific beta-glucan display. PLoS Pathog 2005 1 3 e30
23. Luther K, Torosantucci A, Brakhage A A., Heesemann J, Ebel F. Phagocytosis of Aspergillus fumigatus conidia by murine macrophages involves recognition by the dectin-1 beta-glucan receptor and Toll-like receptor 2. Cell Microbiol 2007 9 2 368-381 (Pubitemid 46092166)
24. Werner J L., Metz A E., Horn D et al. Requisite role for the dectin-1 beta-glucan receptor in pulmonary defense against Aspergillus fumigatus. J Immunol 2009 182 8 4938-4946
25. Chai L Y., de Boer M G., van der Velden W J. et al. The Y238X stop codon polymorphism in the human -glucan receptor dectin-1 and susceptibility to invasive aspergillosis. J Infect Dis 2011 203 5 736-743
26. Bochud P Y., Chien J W., Marr K A. et al. Toll-like receptor 4 polymorphisms and aspergillosis in stem-cell transplantation. N Engl J Med 2008 359 17 1766-1777
27. Gerson S L., Talbot G H., Hurwitz S, Strom B L., Lusk E J., Cassileth P A. Prolonged granulocytopenia: the major risk factor for invasive pulmonary aspergillosis in patients with acute leukemia. Ann Intern Med 1984 100 3 345-351 (Pubitemid 14156535)
28. Wald A, Leisenring W, van Burik J A., Bowden R A. Epidemiology of Aspergillus infections in a large cohort of patients undergoing bone marrow transplantation. J Infect Dis 1997 175 6 1459-1466 (Pubitemid 27225051)
29. Denning D W. Invasive aspergillosis. Clin Infect Dis 1998 26 4 781-803 quiz 804-805
30. Greene R. The radiological spectrum of pulmonary aspergillosis. Med Mycol 2005 43 Suppl 1 S147-S154 (Pubitemid 41038563)
31. Caillot D, Couaillier J F., Bernard A et al. Increasing volume and changing characteristics of invasive pulmonary aspergillosis on sequential thoracic computed tomography scans in patients with neutropenia. J Clin Oncol 2001 19 1 253-259 (Pubitemid 32063503)
32. Miceli M H., Maertens J, Buvé K et al. Immune reconstitution inflammatory syndrome in cancer patients with pulmonary aspergillosis recovering from neutropenia: proof of principle, description, and clinical and research implications. Cancer 2007 110 1 112-120 (Pubitemid 46986424)
33. Baddley J W., Andes D R., Marr K A. et al. Factors associated with mortality in transplant patients with invasive aspergillosis. Clin Infect Dis 2010 50 12 1559-1567
34. von Eiff M, Roos N, Schulten R, Hesse M, Zühlsdorf M, van de Loo J. Pulmonary aspergillosis: early diagnosis improves survival. Respiration 1995 62 6 341-347
35. Denning D W., Follansbee S E., Scolaro M, Norris S, Edelstein H, Stevens D A. Pulmonary aspergillosis in the acquired immunodeficiency syndrome. N Engl J Med 1991 324 10 654-662
36. Kramer M R., Denning D W., Marshall S E. et al. Ulcerative tracheobronchitis after lung transplantation: a new form of invasive aspergillosis. Am Rev Respir Dis 1991 144 3 Pt 1 552-556
37. Binder R E., Faling L J., Pugatch R D., Mahasaen C, Snider G L. Chronic necrotizing pulmonary aspergillosis: a discrete clinical entity. Medicine (Baltimore) 1982 61 2 109-124 (Pubitemid 12158547)
38. Gefter W B., Weingrad T R., Epstein D M., Ochs R H., Miller W T. Semi-invasive pulmonary aspergillosis: a new look at the spectrum of aspergillus infections of the lung. Radiology 1981 140 2 313-321 (Pubitemid 11039952)
39. Hope W W., Walsh T J., Denning D W. The invasive and saprophytic syndromes due to Aspergillus spp. Med Mycol 2005 43 Suppl 1 S207-S238 (Pubitemid 41038572)
40. Denning D W., Riniotis K, Dobrashian R, Sambatakou H. Chronic cavitary and fibrosing pulmonary and pleural aspergillosis: case series, proposed nomenclature change, and review. Clin Infect Dis 2003 37 Suppl 3 S265-S280 (Pubitemid 37260464)
41. Felton T W., Baxter C, Moore C B., Roberts S A., Hope W W., Denning D W. Efficacy and safety of posaconazole for chronic pulmonary aspergillosis. Clin Infect Dis 2010 51 12 1383-1391
42. Muñoz P, Alcalá L, Sánchez Conde M et al. The isolation of Aspergillus fumigatus from respiratory tract specimens in heart transplant recipients is highly predictive of invasive aspergillosis. Transplantation 2003 75 3 326-329 (Pubitemid 36222956)
43. Horvath J A., Dummer S. The use of respiratory-tract cultures in the diagnosis of invasive pulmonary aspergillosis. Am J Med 1996 100 2 171-178 (Pubitemid 26062511)
44. Herbrecht R, Letscher-Bru V, Oprea C et al. Aspergillus galactomannan detection in the diagnosis of invasive aspergillosis in cancer patients. J Clin Oncol 2002 20 7 1898-1906 (Pubitemid 34273282)
45. Maertens J, Verhaegen J, Lagrou K, Van Eldere J, Boogaerts M. Screening for circulating galactomannan as a noninvasive diagnostic tool for invasive aspergillosis in prolonged neutropenic patients and stem cell transplantation recipients: a prospective validation. Blood 2001 97 6 1604-1610 (Pubitemid 32217224)
46. Verweij P E., Mennink-Kersten M A. Issues with galactomannan testing. Med Mycol 2006 44 Suppl 179-183 (Pubitemid 44524102)
47. Hope W W., Petraitis V, Petraitiene R, Aghamolla T, Bacher J, Walsh T J. The initial 96 hours of invasive pulmonary aspergillosis: histopathology, comparative kinetics of galactomannan and (1->3) -d-glucan and consequences of delayed antifungal therapy. Antimicrob Agents Chemother 2010 54 11 4879-4886
48. Koo S, Bryar J M., Baden L R., Marty F M. Prognostic features of galactomannan antigenemia in galactomannan-positive invasive aspergillosis. J Clin Microbiol 2010 48 4 1255-1260
49. Maertens J, Maertens V, Theunissen K et al. Bronchoalveolar lavage fluid galactomannan for the diagnosis of invasive pulmonary aspergillosis in patients with hematologic diseases. Clin Infect Dis 2009 49 11 1688-1693
50. Odabasi Z, Mattiuzzi G, Estey E et al. Beta-D-glucan as a diagnostic adjunct for invasive fungal infections: validation, cutoff development, and performance in patients with acute myelogenous leukemia and myelodysplastic syndrome. Clin Infect Dis 2004 39 2 199-205 (Pubitemid 38971490)
51. Obayashi T, Yoshida M, Mori T et al. Plasma (1>3)-beta-D-glucan measurement in diagnosis of invasive deep mycosis and fungal febrile episodes. Lancet 1995 345 8941 17-20
52. Donnelly J P. Polymerase chain reaction for diagnosing invasive aspergillosis: getting closer but still a ways to go. Clin Infect Dis 2006 42 4 487-489 (Pubitemid 43202520)
53. Herbrecht R, Denning D W., Patterson T F. et al, Invasive Fungal Infections Group of the European Organisation for Research and Treatment of Cancer and the Global Aspergillus Study Group. Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis. N Engl J Med 2002 347 6 408-415 (Pubitemid 34851833)
54. Alvarez-Lerma F, Allepuz-Palau A, Garcia M P. et al, Voriconazole Study Group in Critically Ill Patients. Impact of intravenous administration of voriconazole in critically ill patients with impaired renal function. J Chemother 2008 20 1 93-100 (Pubitemid 351428669)
55. Eiden C, Peyrière H, Cociglio M et al, Network of the French Pharmacovigilance Centers. Adverse effects of voriconazole: analysis of the French Pharmacovigilance Database. Ann Pharmacother 2007 41 5 755-763 (Pubitemid 46752655)
56. Steinbach W J., Stevens D A. Review of newer antifungal and immunomodulatory strategies for invasive aspergillosis. Clin Infect Dis 2003 37 Suppl 3 S157-S187 (Pubitemid 37260461)
57. Thompson G R. III, Rinaldi M G., Pennick G, Dorsey S A., Patterson T F., Lewis J S. II. Posaconazole therapeutic drug monitoring: a reference laboratory experience. Antimicrob Agents Chemother 2009 53 5 2223-2224
58. Ullmann A J., Lipton J H., Vesole D H. et al. Posaconazole or fluconazole for prophylaxis in severe graft-versus-host disease. N Engl J Med 2007 356 4 335-347 (Pubitemid 46148776)
59. Cornely O A., Maertens J, Winston D J. et al. Posaconazole vs. fluconazole or itraconazole prophylaxis in patients with neutropenia. N Engl J Med 2007 356 4 348-359 (Pubitemid 46148777)
60. Courtney R, Wexler D, Radwanski E, Lim J, Laughlin M. Effect of food on the relative bioavailability of two oral formulations of posaconazole in healthy adults. Br J Clin Pharmacol 2004 57 2 218-222 (Pubitemid 38223535)
61. De Beule K, Van Gestel J. Pharmacology of itraconazole. Drugs 2001 61 Suppl 1 27-37 (Pubitemid 32151110)
62. Andes D, Pascual A, Marchetti O. Antifungal therapeutic drug monitoring: established and emerging indications. Antimicrob Agents Chemother 2009 53 1 24-34
63. Bennett J E. Echinocandins for candidemia in adults without neutropenia. N Engl J Med 2006 355 11 1154-1159 (Pubitemid 44394921)
64. Viscoli C, Herbrecht R, Akan H et al, Infectious Disease Group of the EORTC. An EORTC Phase II study of caspofungin as first-line therapy of invasive aspergillosis in haematological patients. J Antimicrob Chemother 2009 64 6 1274-1281
65. Marr K A., Boeckh M, Carter R A., Kim H W., Corey L. Combination antifungal therapy for invasive aspergillosis. Clin Infect Dis 2004 39 6 797-802 (Pubitemid 39244292)
66. Patterson T F., Boucher H W., Herbrecht R et al, European Organization for Research and Treatment of Cancer (EORTC) Invasive Fungal Infections Group (IFIG) Pfizer Global Aspergillus Study Group. Strategy of following voriconazole versus amphotericin B therapy with other licensed antifungal therapy for primary treatment of invasive aspergillosis: impact of other therapies on outcome. Clin Infect Dis 2005 41 10 1448-1452 (Pubitemid 41579987)
67. Bates D W., Su L, Yu D T. et al. Mortality and costs of acute renal failure associated with amphotericin B therapy. Clin Infect Dis 2001 32 5 686-693 (Pubitemid 32221925)
68. Cornely O A., Maertens J, Bresnik M et al, AmBiLoad Trial Study Group. Liposomal amphotericin B as initial therapy for invasive mold infection: a randomized trial comparing a high-loading dose regimen with standard dosing (AmBiLoad trial). Clin Infect Dis 2007 44 10 1289-1297 (Pubitemid 46717290)
69. Winston D J., Bartoni K, Territo M C., Schiller G J. Efficacy, safety, and breakthrough infections associated with standard long-term posaconazole antifungal prophylaxis in allogeneic stem cell transplantation recipients. Biol Blood Marrow Transplant 2011 17 4 507-515
70. Howard S J., Cerar D, Anderson M J. et al. Frequency and evolution of Azole resistance in Aspergillus fumigatus associated with treatment failure. Emerg Infect Dis 2009 15 7 1068-1076
71. Balajee S A., Gribskov J L., Hanley E, Nickle D, Marr K A. Aspergillus lentulus sp. nov., a new sibling species of A. fumigatus. Eukaryot Cell 2005 4 3 625-632 (Pubitemid 40383765)
72. Balajee S A., Weaver M, Imhof A, Gribskov J, Marr K A. Aspergillus fumigatus variant with decreased susceptibility to multiple antifungals. Antimicrob Agents Chemother 2004 48 4 1197-1203 (Pubitemid 38405473)
73. Denning D W., Park S, Lass-Florl C et al. High-frequency triazole resistance found in nonculturable Aspergillus fumigatus from lungs of patients with chronic fungal disease. Clin Infect Dis 2011 52 9 1123-1129